Drug discovery

#Cell Science #Drug discovery

Webinar: Using ENFINIA™ cell-free synthesised DNA for rapid protein expression and screening in the myTXTL® cell-free system – 19.03.2025

Cell-free transcription-translation (TXTL) systems can be used for rapid and flexible protein expression and screening workflows, powering protein engineering and discovery, synthetic biology, AI-driven approaches, biomanufacturing, and more. However, reliance on plasmid DNA templates for expression requires time-consuming cloning steps, limiting speed and efficiency. In this webinar, supported by… Read More

#Webinars

#Cell Science #Drug discovery

Guide: Next Generation Cell-free Gene Synthesis

Struggling to make sense of the strategies, technology and trade-offs when developing a DNA  supply chain? Elegen created a comprehensive overview of the evolving field of gene synthesis. This guide contains a detailed comparison of 10 industry-leading vendors, including key metrics such as error rate, turnaround time, cost, and maximum… Read More

#Guides

#Drug discovery

Whitepaper: Introduction to Humanised Immune System Mice

Unlock the Power of Humanised Immune System Mice Traditional mouse models have limitations in recapitulating human biology — but humanised immune system (HIS) mice offer a more predictive approach. These advanced models bring you closer to clinical relevance. Download this whitepaper to discover: The evolution of immunodeficient mice Key humanisation… Read More

#Whitepapers

#Cancer research #Cell therapy #Drug development #Drug discovery #Oncology

New DDW Highlights podcast: 24 March 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week the DDW news round-up takes a look at developments in cancer research,… Read More

#News

Monoclonal antibody
#Antibodies #Drug discovery #Immunology / Virology & Vaccines #Therapeutic Antibodies

Antibody therapies: A core technology of the past, present, and the future

Jeff Fischer, President of Longhorn Vaccines & Diagnostics, discusses the evolution of antibody therapies from early serum treatments to targeted monoclonal antibodies, their impact on disease prevention and treatment, and the growing acceptance of antibody-based alternatives to traditional vaccines. Antibody therapy has been used to prevent and treat disease for over… Read More

#Exclusive Content

Ion channel modulators
#CNS #Drug discovery #Ion channel modulators #Therapeutic targets #Webinar

Register now: Understand current and future ion channel targets

Ion channels are often regarded as ‘difficult’ drug discovery targets, but this webinar, hosted by DDW and supported by Axxam, will provide data and insights showing that this negative perception is inaccurate and that there has been remarkable progress in bringing novel ion channel modulators into the clinic over the… Read More

Webinar date:
Supported by Axxam
#News

#Cell Science #Drug discovery

App Note: Transform Drug Discovery with Single Cell Precision

Scale Bio’s ScalePlex technology and Single Cell RNA Sequencing Kit v1.1 are revolutionising drug discovery by making large-scale single cell sample and condition screening possible.  Libraries from 384 drug conditions were prepared in just 1.5 days 90% reduction in processing time >80% cell recovery rate and >3000 unique transcripts per… Read More

#App Notes

#Cancer research #Cell therapy #Drug development #Drug discovery #Oncology

This week in drug discovery (17-21 March) 

News round-up for 17-21 March by DDW Senior Digital Content Editor Diana Spencer. This week the DDW news round-up takes a look at developments in cancer research, including AZ’s acquisition of EsoBiotec, positive trial results for an allogeneic T-cell therapy, and a new drug target for glioblastoma. Read More

#News

TEM micrograph of kidney proximal tubule cells
#Drug development #Drug discovery #Drug toxicity #eBook #In vitro #In vitro assays

eBook: A guide to predictive in vitro renal proximal tubule models

This latest eBook provides a comprehensive guide to predictive in vitro renal proximal tubule models for safety, efficacy and transporter studies. The Newcells Renal Proximal Tubule Cells Model eBook covers topics including: Cross-species comparison of drug handling Transporter mediated drug-drug interactions Drug-induced renal toxicity New drug modalities e.g. RNA therapeutics… Read More

#News

#Drug development #Drug discovery #Drug toxicity #In vitro #In vitro assays

Your comprehensive guide to predictive in vitro renal proximal tubule models for safety, efficacy and transporter studies

The Newcells Renal Proximal Tubule Cells Model eBook covers topics including: Cross-species comparison of drug handling Transporter mediated drug-drug interactions Drug-induced renal toxicity New drug modalities e.g. RNA therapeutics and how to measure mitochondrial health… Read More

#Resources

#Artificial intelligence (AI) #Data automation #Drug discovery #Laboratory data #Webinar

Webinar: The key to a successful AI data automation strategy

The adoption of AI/ML in life science R&D is hindered by the lack of high-quality, well-structured data and metadata, a challenge exacerbated by a proliferation of proprietary instrument data formats, siloed lab software applications, and the absence of wet lab-friendly data automation platforms. While some workflow-specific solutions exist, they are… Read More

Webinar date:
Supported by Benchling
#News

#Drug discovery #Protein chemistry / Proteomics #Protein engineering #Synthetic biology #Synthetic DNA #Webinar

Webinar: Synthetic DNA for protein screening in a cell-free system

A new webinar is now open for registration entitled ‘Using ENFINIA cell-free synthesised DNA for rapid protein expression and screening in the myTXTL cell-free system‘. Cell-free transcription-translation (TXTL) systems can be used for rapid and flexible protein expression and screening workflows, powering protein engineering and discovery, synthetic biology, AI-driven… Read More

Webinar date:
Supported by Elegen Bio
#News

#Clinical trial design #Clinical trials #Drug development #Drug discovery

New DDW Highlights podcast: 17 March 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Clinical trials of all stages have dominated the DDW news section this week. All… Read More

#News

Ion channel modulators
#CNS #Drug discovery #Ion channel modulators #Therapeutic targets #Webinar

Webinar: Current trends in ion channel drug discovery

Ion channels are often regarded as ‘difficult’ drug discovery targets, but this webinar, hosted by DDW and supported by Axxam, will provide data and insights showing that this negative perception is inaccurate and that there has been remarkable progress in bringing novel ion channel modulators into the clinic over the… Read More

Webinar date:
Supported by Axxam
#News

#Clinical trial design #Clinical trials #Drug development #Drug discovery

This week in drug discovery (10-14 March) 

News round-up for 10-14 March by DDW Senior Digital Content Editor Diana Spencer. Clinical trials of all stages have dominated the DDW news section this week. All the stories represent a significant step forward for drug discovery, either due to the innovative nature of the therapies being studied,… Read More

#News

Ion channel modulators
#CNS #Drug discovery #Ion channel modulators #Therapeutic targets

Ion channel drug discovery – current trends and future opportunities

Ion channels are often regarded as ‘difficult’ drug discovery targets, but this webinar, hosted by DDW and supported by Axxam, provides data and insights showing that this negative perception is inaccurate and that there has been remarkable progress in bringing novel ion channel modulators into the clinic over the last… Read More

Webinar date:
Supported by Axxam
#Webinars